LMO1 and acute lymphoblastic leukemia: Even though <1% of T-ALL patients carry translocations involving LMO1, ∼50% express significant levels of LMO1,3 thus suggesting that aberrant activation of regulatory elements within the LMO1 gene locus represents a common feature of dysregulated transcriptional programs in T-ALL.